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Abstract
Rationale:Cystoisosporiasis is an intestinal infectious disease caused by a coccidian protozoa, Cystoisospora belli (C. belli). It can
cause prolonged and refractory diarrhea most commonly in immunocompromised patients, while immunocompetent individuals
usually exhibit no symptoms or self-limited diarrhea.
Patientconcerns:We herein report a case of chronic cystoisosporiasis in an immunocompetent patient. A 62-year-old man, who
had been first diagnosed with cystoisosporiasis 15years ago and had been treated with oral administration of trimethoprim-
sulfamethoxazole (TMP-SMX), complained of persistent watery diarrhea. He was negative for anti-human immunodeficiency virus
antibody and anti-human T-cell leukemia virus type 1 (HTLV-1) antibody.
Diagnosis: Biopsy specimens from the duodenum revealed oocysts in the atrophic absorptive epithelium and protozoa were
detected through stool examination, indicating the recurrence of cystoisosporiasis. Capsule endoscopy showed diffuse atrophic
mucosa with white villi in the entire small intestine. We diagnosed him with chronic cystoisosporiasis that occurred in an
immunocompetent adult.
Interventions: Since oral administration of TMP-SMX and ciprofloxacin were ineffective, the intravenous administration of TMP-
SMX was initiated.
Outcomes: Intravenous TMP-SMX exhibited a significant improvement.
Lessons: This case indicates that even immunocompetent individuals may develop recurrent and refractory cystoisosporiasis.
Furthermore, intravenous treatment of antibiotic agents should be considered when the impaired absorptive ability from the small
intestine is suspected.
Abbreviations: AIDS = acquired immune deficiency syndrome, ATL = adult T-cell leukemia, C. belli = Cystoisospora belli, TMP-
SMX = trimethoprim-sulfamethoxazole.
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1. Introduction
Cystoisospora belli (C. belli) is a protozoan parasite that
primarily infects the epithelial cells of the small intestine.[1] It
is present worldwide but is mostly found in tropics and
subtropics.[1] Humans are thought to be only a host of C. belli
since there is no report that C. belli infects other animals.[2]
People become infected by ingesting oocysts excreted from the
stool of infected patients.[3]C. belli infection, called cystoisospor-
iasis, is characterized by watery and non-bloody diarrhea. Most
cases are reported in patients who are immunocompromised
hosts with acquired immune deficiency syndrome (AIDS) or adult
T-cell leukemia (ATL).[4,5] Diarrhea is usually prolonged and
refractory and leads to malabsorption syndrome.[6] In contrast,
C. belli infection is often either asymptomatic or associated with
self-limited acute diarrhea in immunocompetent hosts.[6]
According to the therapeutic guidelines for patients with AIDS,
trimethoprim-sulfamethoxazole (TMP-SMX) is recommended as
the first-line antibiotic agent for cystoisosporiasis.[5] When TMP-
SMX is ineffective or intolerant, ciprofloxacin should be
considered as an alternative treatment.[5,7] However, in cases
of severe damage to epithelial cells of the small intestine, these
medicines are not absorbed adequately. In this situation, it is
recommended to administer medicines intravenously.[5] Here, we
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report a case of chronic C. belli infection that occurred in an
immunocompetent adult. Capsule endoscopy and histo-
pathological findings revealed the severe atrophic mucosa in
the small intestine. The patient was successfully treated by
intravenous administration of TMP-SMX, but not its oral
administration.
2. Case report
A 62-year-old man visited the out-patient department of the
Shiga University of Medical Science Hospital with prolonged
watery diarrhea and lower-extremity weakness. He was once
diagnosed with Cystoisospora infection 15years ago and treated
with oral TMP-SMX. However, diarrhea lasted intermittently
after the treatment. Laboratory studies on visit showed
eosinophilia (778 /ml), hypoalbuminemia (3.3g/dl), hypokalemia
(3.0mmol/L), and normal serum C-reactive protein (0.02mg/dl)
(Table 1). He was born and raised on a small island located in
south Kyushu, Japan, where human T-cell leukemia virus type 1
(HTLV-1) is endemic, and his father died with ATL. However, he
was negative for anti-HTLV-1 antibody (Table 1). Additional
laboratory examinations such as human immunodeficiency virus
antigen/antibody test, serum soluble interleukin-2 receptor, the
CD4 count were normal (Table 1). We performed a stool
microscopy examination and found the presence of protozoa that
exhibited green autofluorescence under ultraviolet exposure
(Fig. 1A). Consistently, esophagogastroduodenoscopy showed
diffuse atrophic mucosa in the duodenum (Fig. 1B) and a
microscopic examination of the duodenum biopsy specimens
revealed invaded oocysts in the atrophic absorptive epithelial
cells (Fig. 1C). A contrast-enhanced computed tomography
indicated excess fluid in the entire small intestine with no wall
thickness (Fig. 2A). Therefore, he underwent capsule endoscopy
(PillCam SB 3; Medtronic, Dublin, Ireland) to observe the
mucosa of the small intestine and found the atrophic mucosa with
diffuse white villi in the entire small intestine and no apparent
erosions and ulcers (Fig. 2B). These findings indicated chronic
infection with C. belli.
We started oral administration of 2 tablets of trimethoprim-
sulfamethoxazole (TMP-SMX; 160mg of TMP, 800mg of SMX
per day), followed by ciprofloxacin (400mg per day). However,
both failed to improve the patient’s symptoms. Afterward, he
received central parenteral nutrition and was treated with
intravenous administration of TMP-SMX (15mg per kg per
day based on TMP component) for 10days, since an impairment
of drug absorption was suspected. After this, his symptoms were
remarkably improved, and the protozoa became undetectable in
Table 1
Laboratory findings on admission.
Parameter Result Normal Range Parameter Result Normal Range
WBC (/ml) 6600 3000–8000 CRP (mg/dl) 0.02 000–0.30
Neut (%) 62.3 40.0–74.0 IgM (mg/dl) 50 35–220
Lymph (%) 18.8 15.0–48.0 IgG (mg/dl) 1312 870–1700
Eosin (%) 11.8 0.0–7.0 IgA (mg/dl) 412 110–410
Mono (%) 6.2 2.0–12.0 IgE (IU/ml) 3901.1 0.0–400.0
CD4 (/ml) 870 500–1200 sIL-2R (U/ml) 418 121–613
Hb (g/dl) 13.1 12.4–17.0 Glucose (mg/dl) 108 70–109
Ht (%) 36.5 38.0–54.0 HbA1c (%) 5.4 4.6–6.2
Plt (x104/ml) 21.0 15.0–40.0 ESR (mm/hour) 5.0 2.0–10.0
TP (g/dl) 6.3 6.3–8.3 ANA ()
Alb (g/dL) 3.3 4.0–5.0 HBs-Ag ()
Na (mEq/L) 139 138–146 HCV-Ab ()
K (mEq/L) 3.0 3.6–4.9 HIV-Ag/Ab ()
Cl (mEq/L) 109 99–109 TP-Ag ()
T. chol (mg/dl) 127 128–219 HTLV1-Ab ()
TG (mg/dl) 57 30–149
Alb= albumin, ANA= anti-nuclear antibody, CRP= C-reactive protein, Eosin= eosinophil, ESR= erythrocyte sedimentation rate, Hb= hemoglobin, HbA1c= glycated hemoglobin, HBs-Ag= hepatitis B surface
antigen, HCV-Ab = hepatitis C virus antibody, HIV-Ag/Ab = human immunodeficiency virus antigen/antibody, Ht = hematocrit, HTLV-1-Ab = human T cell leukemia virus type 1 antibody, Lymph = lymphocyte,
Mono =monocyte, Neut= neutrophil, Plt= platelet, sIL-2R= soluble interleukin-2 receptor, T. chol = total cholesterol, TG = triglyceride, TP = total protein, TP-Ag = treponema pallidum antigen, WBC= white
blood cell.
Figure 1. (A) A light microscopic image (left panel) and UV fluorescence
microscopy image (right panel) of the stool. (B) EGD showed the marked
atrophic mucosa in the duodenum. (C) The H/E-stained section revealed the
presence of an oocyst within the absorptive epithelial cells (solid arrow). Original
magnification 100.
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the stool. So far, 9 months have passed since the intravenous
intervention, and there is no evidence of recurrence.
3. Discussion
We experienced a case of chronic C. belli infection in an
immunocompetent adult. C. belli is a protozoan pathogen that
causes an opportunistic infection primarily in immunocompro-
mised patients with AIDS and/or ATL.[8] Cystoisosporiasis is also
reported in patients with non-Hodgkin lymphoma, alcoholism,
and ulcerative colitis taking azathioprine and anti-TNF-a
antibody treatment.[9–11] However, only a few reports described
C. belli infection in immunocompetent individuals.[12,13] In our
case, there was no evidence of immunocompromised status by
extensive examinations. Given that ATL was endemic in his
birthplace, it is speculated that he might be infected with C. belli
in infancy and become chronic. Furthermore, C. belli infection
was chronic because the patient exhibited intermittent diarrhea
for more than 15years. Severe atrophic mucosa observed in
capsule endoscopy also supported chronic infection. These
endoscopic images are invaluable in understanding how
cystoisosporiasis affects the small intestinal mucosa.
The diagnosis of C. belli infection is usually based on the
detection of oocysts in the stool. It can be also found in an
intestinal biopsy specimen.[5] However, it can be difficult to
detect by routine examinations. Therefore, the detection of
autofluorescence is helpful to identifyC. belli in the stool whenC.
belli infection is suspected.[14] Interestingly, our case showed
prominent eosinophilia that is one of the unique features of
cystoisosporiasis.[15] Other protozoan infections generally do not
cause eosinophilia; this finding is useful for diagnosing
cystoisosporiasis. Of note, our case also showed markedly
elevated serum IgE levels, suggesting an excess allergic response
in the small intestine.
Treatment of cystoisosporiasis was usually performed with
oral administration of antibiotic agents. However, the oral
administration of drugs was ineffective in our patients. This is
presumably due to the impaired absorption ability associating
with severe mucosal atrophy. It should be noted that intravenous
administration of antibiotic agents is recommended for the
treatment ofC. belli infection when impaired mucosal absorption
is suspected.[5] Indeed, intravenously administered TMP-SMX
quickly improved his symptoms.
In conclusion, this case emphasizes that immunocompetent
individuals can develop chronic and recurrent cystoisosporiasis.
Cystoisosporiasis should be taken into account in patients with
chronic diarrhea who have mucosal atrophy in the small
intestine. In addition, capsule endoscopy is thought to be a
useful tool for the early detection of mucosal atrophy.
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